Delineating Metabolic Dysfunction-Associated Steatotic Liver Disease and Comorbid Risk With Clinical, Blood and Metabolomic Parameters-A UK Biobank Analysis
{{output}}
Background/objectives: Ascertaining risk of and prognostication tools for metabolic dysfunction-associated steatotic liver disease (MASLD) remain suboptimal. Using the UK Biobank, we investigated the role of multivariate supervis... ...
